Impact of Switching Vicodin, Norco, Lortab to Schedule II

Authors

Adam M. Kaye, University of the PacificFollow

ORCiD

Adam M. Kaye: 0000-0002-7224-3322

Document Type

Blog Post

Publication Title

RxEconsult, LLC

Publication Date

1-28-2013

Abstract

On January 25, 2013 an FDA advisory panel of experts voted 19 to 10 to change hydrocodone containing products from schedule III controlled drugs to the more restricted schedule II controlled substance category. The FDA is expected to adopt this recommendations despite strong opposition from several groups. Hydrocodone medications include Vicodin, Lortab, Norco, and generic versions.

Recommended Citation

Kaye, A. M. (2013). Impact of Switching Vicodin, Norco, Lortab to Schedule II. RxEconsult, LLC, ,
https://scholarlycommons.pacific.edu/phs-facarticles/650